WHO may reject Canadian-made Medicago COVID-19 vaccine because of ties to big tobacco
OTTAWA — The World Health Organization says it expects to reject the COVID-19 vaccine candidate from Canada's Medicago because of the company's ties to big tobacco.
The two-dose Medicago Covifenz vaccine was authorized in Canada last month for adults between 18 and 64 years old.
Medicago also applied for an emergency use licence through the World Health Organization, which would allow it to seek contracts for sale in a number of other countries as well as to the COVAX vaccine sharing alliance.
But Dr. Mariângela Simão, WHO's assistant director general for drug access, vaccines and pharmaceuticals, said Wednesday the WHO has strict policies about engaging with tobacco companies and arms manufacturers.
https://www.msn.com/en-us/news/canada/who-may-reject-canadian-made-medicago-covid-19-vaccine-because-of-ties-to-big-tobacco/ar-AAVcgPg